José Manuel Lozano Selected Research

José Manuel Lozano Research Topics

10	Malaria 11/2017 - 01/2003
6	Infections 11/2020 - 10/2007
2	Parasitemia 01/2011 - 02/2009
1	COVID-19 11/2020
1	Cutaneous Leishmaniasis 04/2011
1	Communicable Diseases (Infectious Diseases) 12/2010
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 12/2008
1	Falciparum Malaria (Plasmodium falciparum Malaria) 07/2004
1	Necrosis 02/2003
1	Proteinuria 02/2003

6	Peptides (Polypeptides)IBA 11/2017 - 02/2003
5	AntigensIBA 11/2020 - 10/2007
5	VaccinesIBA 11/2017 - 07/2004
5	Merozoite Surface Protein 1 (MSA1)IBA 01/2011 - 01/2003
4	AntibodiesIBA 10/2013 - 10/2007
3	Immunoglobulins (Immunoglobulin)IBA 10/2013 - 02/2009
3	AmidesIBA 01/2011 - 10/2007
2	Synthetic Vaccines (Recombinant Vaccines)IBA 11/2020 - 12/2010
2	Biological ProductsIBA 10/2013 - 01/2003
1	Proteins (Proteins, Gene)FDA Link 08/2014
1	EpitopesIBA 10/2013
1	cecropin AIBA 04/2011
1	dermaseptinIBA 04/2011
1	Antimicrobial PeptidesIBA 04/2011
1	Drosophila Anp proteinIBA 04/2011
1	EnzymesIBA 01/2011
1	Immunoglobulin FragmentsIBA 01/2011
1	Subunit VaccinesIBA 12/2010
1	Therapeutic UsesIBA 12/2010
1	Amino Acids FDA Link 12/2010
1	Peptide FragmentsIBA 12/2009
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2009
1	Monoclonal AntibodiesIBA 02/2009
1	NK Cell Lectin-Like Receptor Subfamily CIBA 12/2008
1	Neutralizing AntibodiesIBA 10/2007
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2004
1	ProstaglandinsIBA 02/2003
1	Prostaglandins EIBA 02/2003
1	DNA (Deoxyribonucleic Acid)IBA 02/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2003
1	GalactosamineIBA 02/2003

1	Therapeutics 12/2008
1	Intravenous Administration 02/2003